Back to Fundsmith LLPCPRX
CPRX5 quarters
Position history for Fundsmith LLP's holdings in CATALYST PHARMACEUTICALS INC
Fundsmith LLP holds 844,887 shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $20.9M as of 2026-Q1. The position was decreased (-74.9% shares). CPRX represents 0.2% of Fundsmith LLP's portfolio.
Current Value
$20.9M
Current Shares
844,887
Total Value Change
-$31.2M
Total Shares Change
-1.3M
Quarter-by-Quarter History
Other major holders of CPRX: BlackRock, Inc.